Edgewise Therapeutics, Inc. Annual Depreciation in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Edgewise Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2023.
  • Edgewise Therapeutics, Inc. Depreciation for the quarter ending September 30, 2024 was $500K, a 25% increase year-over-year.
  • Edgewise Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2024 was $2.03M, a 87.9% increase year-over-year.
  • Edgewise Therapeutics, Inc. annual Depreciation for 2023 was $1.55M, a 321% increase from 2022.
  • Edgewise Therapeutics, Inc. annual Depreciation for 2022 was $368K, a 35.3% increase from 2021.
  • Edgewise Therapeutics, Inc. annual Depreciation for 2021 was $272K, a 47% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.55M +$1.18M +321% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $368K +$96K +35.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $272K +$87K +47% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-23
2020 $185K Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.